Skip to main content
SpringerLink
Log in

Rituximab in CD20 positive multiple myeloma

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. Moreau P, Voillat L, Benboukher L, Mathiot C, Dumontet C, Robillard N et al. Rituximab in CD20 positive multiple myeloma. Leukemia 2007; 21: 835–836.

    Article  CAS  Google Scholar 

  2. Gozzetti A, Fabbri A, Lazzi S, Bocchia M, Lauria F . Reply to Rituximab activity in CD20 positive multiple myeloma. Leukemia 2007; 21: 1842–1843.

    Article  CAS  Google Scholar 

  3. Matsui W, Huff CA, Wang Q, Malehorn MT, Barber J, Tanhehco Y et al. Characterization of clonogenic multiple myeloma cells. Blood 2004; 103: 2332–2336.

    Article  CAS  Google Scholar 

  4. Treon SP, Pilarski LM, Belch AR, Kelliher A, Preffer FI, Shima Y et al. CD20-directed serotherapy in patients with multiple myeloma: biologic considerations and therapeutic applications. J Immunother (1997) 2002; 25: 72–81.

    Article  Google Scholar 

  5. Zojer N, Kirchbacher K, Vesely M, Hubl W, Ludwig H . Rituximab treatment provides no clinical benefit in patients with pretreated advanced multiple myeloma. Leuk Lymphoma 2006; 47: 1103–1109.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Servicio de Hematología, Hospital San Pedro de Alcántara, Avda. Pablo Naranjo s/n, Cáceres, Spain

    J M Bergua, C Cabrera, E G Arteta & J Prieto

Authors
  1. J M Bergua
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C Cabrera
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E G Arteta
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J Prieto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J M Bergua.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bergua, J., Cabrera, C., Arteta, E. et al. Rituximab in CD20 positive multiple myeloma. Leukemia 22, 1082–1083 (2008). https://doi.org/10.1038/sj.leu.2405010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2405010

  • Springer Nature Limited

This article is cited by

Search

Navigation